By webmin on
Phone
N/A
Email
EarlyAccess@amicusrx.com
ClinicalTrials.gov URL
https://clinicaltrials.gov/ct2/results?cond=&term=&spons=amicus&cntry=&state=&city=&dist=&Search=Search&recrs=a&recrs=b&recrs=d
Acknowledgement
3 business days
EA Page
https://www.amicusrx.com/advocacy/expanded-access/
Sponsor
Amicus Therapeutics
EA Policies for Single Patient

Requests for Early Access cannot be made directly by an individual patient or a patient’s parent/legal guardian or caregiver. Patients and caregivers seeking general information may reach out to Amicus’ Global Patient & Professional Advocacy Department at patientadvocacy@amicusrx.com or call toll-free in the United States at 1-866-9AMICUS (1-866-926-4287), or +44-1753-888-567 for International inquiries.

Expanded Access Listings

Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Conditions
Pompe Disease Infantile-Onset

This is an expanded access program (EAP) for eligible participants designed to provideaccess to ATB200/AT2221.